RAPT Therapeutics, Inc. (RAPT)
Mar 3, 2026 - RAPT was delisted (reason: acquired by GSK)
58.02
0.00 (0.00%)
Inactive · Last trade price
on Mar 2, 2026
RAPT Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$56.22
Upside
-3.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy → Hold Downgrades $58 | Buy → Hold | Downgrades | $58 | -0.03% | Jan 21, 2026 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $58 | Buy → Hold | Downgrades | $58 | -0.03% | Jan 21, 2026 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $58 | Buy → Hold | Downgrades | $58 | -0.03% | Jan 20, 2026 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $58 | Strong Buy → Hold | Downgrades | $58 | -0.03% | Jan 20, 2026 |
| Clear Street | Clear Street | Strong Buy → Hold Downgrades $60 → $58 | Strong Buy → Hold | Downgrades | $60 → $58 | -0.03% | Jan 20, 2026 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $55 → $57 | Buy | Maintains | $55 → $57 | -1.76% | Nov 12, 2025 |
| Barclays | Barclays | Buy Maintains $58 → $56 | Buy | Maintains | $58 → $56 | -3.48% | Nov 7, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $48 → $72 | Buy | Maintains | $48 → $72 | +24.10% | Nov 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $72 | Strong Buy | Maintains | $27 → $72 | +24.10% | Oct 27, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +20.65% | Oct 27, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $38 → $48 | Buy | Maintains | $38 → $48 | -17.27% | Oct 21, 2025 |
| Barclays | Barclays | Buy Maintains $35 → $58 | Buy | Maintains | $35 → $58 | -0.03% | Oct 21, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $41 → $60 | Strong Buy | Maintains | $41 → $60 | +3.41% | Oct 21, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $13 → $55 | Hold → Buy | Upgrades | $13 → $55 | -5.21% | Oct 20, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.